Orion Corporation: Managers’ Transactions – Niclas Lindstedt

Orion Corporation has received the following disclosure under the Market Abuse Regulation (EU) No 596/2014, in relation to transactions in shares and securities linked thereto in Orion Corporation carried out by managers and their closely associated persons.

Orion Oyj – Managers’ Transactions
________________________________________________________
Person subject to the reporting obligation
Name: Niclas Lindstedt
Function: Other senior manager
Publisher: Orion Oyj
LEI number: 74370029VAHCXDR7B745
Type of notification: FIRST NOTIFICATION
Reference number: 74920/9/8

________________________________________________________
Transaction date: 2024-08-20
Location: NASDAQ HELSINKI LTD (XHEL)
Instrument Type: SHARE
ISIN code: FI0009014377
Nature of transaction: SALE

Transaction data
(1): Volume: 614 Unit price: 46.7 EUR
(2): Volume: 521 Unit price: 46.7 EUR
(3): Volume: 200 Unit price: 46.7 EUR
(4): Volume: 200 Unit price: 46.7 EUR
(5): Volume: 100 Unit price: 46.7 EUR
(6): Volume: 125 Unit price: 46.7 EUR
(7): Volume: 100 Unit price: 46.7 EUR
(8): Volume: 125 Unit price: 46.7 EUR
(9): Volume: 8 Unit price: 46.7 EUR
(10): Volume: 5 Unit price: 46.7 EUR
(11): Volume: 2 Unit price: 46.7 EUR

Aggregated transactions (11):
Volume: 2000 Volume weighted average price: 46.7 EUR

Orion Corporation

Publisher:
Orion Corporation
Communication
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orion.fi/en
http://www.twitter.com/OrionCorpIR

Orion is a global Finnish pharmaceutical company – a builder of well-being for over a century. We develop, manufacture and market human and veterinary pharmaceutical products and active pharmaceutical ingredients. Orion has an extensive portfolio of patented and generic pharmaceuticals and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. The patented products developed by Orion are used, among others, to treat cancer, neurological disorders and respiratory diseases. Orion’s net sales in 2023 amounted to EUR 1,190 million and the company had approximately 3,600 employees at the end of the year. Orion’s A and B shares are listed on Nasdaq Helsinki.